Wizard Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 5.00 M
as on 03-07-2024
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 6.50 Cr
as on 03-07-2024
- Satisfied Charges ₹ 3.60 M
as on 03-07-2024
- Revenue %
(FY 2017)
- Profit 20.54%
(FY 2017)
- Ebitda 2.97%
(FY 2017)
- Net Worth -0.20%
(FY 2017)
- Total Assets -2.51%
(FY 2017)
About Wizard Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.50 Cr. The company has closed loans amounting to ₹3.60 M, as per Ministry of Corporate Affairs (MCA) records.
Baijnath Bajpai and Rajeev Bajpai serve as directors at the Company.
- CIN/LLPIN
U24232RJ2000PTC016627
- Company No.
016627
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2000
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wizard Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Bajpai  | Managing Director | 11-Sep-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Baijnath Bajpai | Director | 16-May-2001 | Current |
Financial Performance and Corporate Structure Insights of Wizard Biotech.
Wizard Biotech Pvt. Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 20.54% increase in profit. The company's net worth dipped by a decrease of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wizard Biotech?
In 2017, Wizard Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Aug 2008 | ₹5.25 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Jun 2007 | ₹8.50 M | Open |
United Western Bank Ltd. Creation Date: 07 Jun 2004 | ₹3.20 M | Open |
How Many Employees Work at Wizard Biotech?
Wizard Biotech has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wizard Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wizard Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
